Literature DB >> 21923311

Opioid side effects and their treatment in patients with chronic cancer and noncancer pain.

Ewan McNicol1.   

Abstract

Opioids are the foundation of standard analgesic regimens for moderate to severe pain due to life-threatening illnesses such as cancer, and are increasingly employed in chronic noncancer pain of the same severity. Opioids are frequently used for long periods in these populations, sometimes for years. However, side effects are common and may reduce quality of life, or become life threatening, and frequently cause patients to discontinue opioid therapy. Successful opioid therapy dictates that benefits of analgesia outweigh safety concerns. The mechanisms, incidence, and treatment or prevention of commonly reported side effects in chronic pain populations are reviewed, employing best available evidence along with empiric practice. General management strategies include switching opioids ("opioid rotation"), discontinuation of concurrent medications that exacerbate side effects, and symptomatic treatment. In addition, recently recognized adverse events that occur after long-term opioid therapy are discussed. High-quality evidence is lacking for the treatment of most side effects, and the true incidence, underlying mechanisms, and clinical implications of long-term responses to opioid therapy are not yet fully understood.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 21923311     DOI: 10.1080/15360280802537225

Source DB:  PubMed          Journal:  J Pain Palliat Care Pharmacother        ISSN: 1536-0288


  8 in total

Review 1.  Pharmacological options for the management of refractory cancer pain-what is the evidence?

Authors:  B Afsharimani; K Kindl; P Good; J Hardy
Journal:  Support Care Cancer       Date:  2015-03-07       Impact factor: 3.603

Review 2.  Methadone for neuropathic pain in adults.

Authors:  Ewan D McNicol; McKenzie C Ferguson; Roman Schumann
Journal:  Cochrane Database Syst Rev       Date:  2017-05-17

3.  Update on prescription extended-release opioids and appropriate patient selection.

Authors:  Michael J Brennan
Journal:  J Multidiscip Healthc       Date:  2013-07-23

4.  Treatment of Severe Pain and Opioid-induced Constipation: An Observational Study of Quality of Life, Resource Use, and Costs in Sweden.

Authors:  Frida Hjalte; Gunnel Ragnarson Tennvall; Karl-Olof Welin; Dagmar Westerling
Journal:  Pain Ther       Date:  2016-11-09

5.  Automated Stereotactic Gamma Ray Radiosurgery to the Pituitary Gland in Terminally Ill Cancer Patients with Opioid Refractory Pain.

Authors:  Eduardo E Lovo; Fidel J Campos; Victor E Caceros; Mario Minervini; Claudia B Cruz; Juan C Arias; William A Reyes
Journal:  Cureus       Date:  2019-06-03

Review 6.  Topical Ketamine with Other Adjuvants: Underutilized for Refractory Cancer Pain? A Case Series and Suggested Revision of the World Health Organization Stepladder for Cancer Pain.

Authors:  Jennifer A Winegarden; Daniel B Carr; Ylisabyth S Bradshaw
Journal:  J Palliat Med       Date:  2020-03-11       Impact factor: 2.947

Review 7.  Abdominal Pain in Inflammatory Bowel Diseases: A Clinical Challenge.

Authors:  Pauline Wils; Bénédicte Caron; Ferdinando D'Amico; Silvio Danese; Laurent Peyrin-Biroulet
Journal:  J Clin Med       Date:  2022-07-22       Impact factor: 4.964

8.  Opioid doses required for pain management in lung cancer patients with different cholesterol levels: negative correlation between opioid doses and cholesterol levels.

Authors:  Zhenhua Huang; Lining Liang; Lingyu Li; Miao Xu; Xiang Li; Hao Sun; Songwei He; Lilong Lin; Yixin Zhang; Yancheng Song; Man Yang; Yuling Luo; Horace H Loh; Ping-Yee Law; Dayong Zheng; Hui Zheng
Journal:  Lipids Health Dis       Date:  2016-03-08       Impact factor: 3.876

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.